Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Petros Pharmaceuticals Inc

PTPI
Current price
0.32 USD -0.0089 USD (-2.73%)
Last closed 0.33 USD
ISIN US71678J1007
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 3 399 989 USD
Yield for 12 month -76.52 %
1Y
3Y
5Y
10Y
15Y
PTPI
21.11.2021 - 28.11.2021

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products, including vacuum erection devices, penile injections, PreBoost, VenoSeal, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York. Address: 1185 Avenue of the Americas, New York, NY, United States, 10036

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1 USD

P/E ratio

Dividend Yield

Current Year

+5 822 388 USD

Last Year

+5 992 054 USD

Current Quarter

+1 421 471 USD

Last Quarter

+1 388 806 USD

Current Year

+908 201 USD

Last Year

+3 702 636 USD

Current Quarter

+374 523 USD

Last Quarter

+1 056 975 USD

Key Figures PTPI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -10 134 383 USD
Operating Margin TTM -160.46 %
PE Ratio
Return On Assets TTM -30.61 %
PEG Ratio
Return On Equity TTM -63.77 %
Wall Street Target Price 1 USD
Revenue TTM 4 120 681 USD
Book Value 0.87 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -28.7 %
Dividend Yield
Gross Profit TTM 6 211 698 USD
Earnings per share -6.25 USD
Diluted Eps TTM -6.25 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -171.24 %

Dividend Analytics PTPI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PTPI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 01.12.2022
Dividend Date

Stock Valuation PTPI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.1381
Price Sales TTM 0.8251
Enterprise Value EBITDA -0.1462
Price Book MRQ 0.4213

Financials PTPI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PTPI

For 52 weeks

0.28 USD 2.27 USD
50 Day MA 0.35 USD
Shares Short Prior Month 294 901
200 Day MA 0.71 USD
Short Ratio 3.08
Shares Short 273 602
Short Percent 3.01 %